Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same

  • Read more about Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same
Finland
03022671.6
Filed on 1997-02-06

Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same

  • Read more about Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same
European Patent
03022671.6
Filed on 1997-02-06

Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta

  • Read more about Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta
Patent Cooperation Treaty
PCT/US03/34023
Filed on 2003-10-24

USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK

  • Read more about USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK
Czech Republic
3204-97
Filed on 1996-04-10

METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...

  • Read more about METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...
Switzerland
96905555.7
Filed on 1996-02-14

METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...

  • Read more about METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...
The Netherlands
96905555.7
Filed on 1996-02-14

METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...

  • Read more about METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...
Luxembourg
96905555.7
Filed on 1996-02-14

Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof

  • Read more about Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof
Hong Kong
03105948.9
Filed on 2003-08-20

PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE

  • Read more about PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE
US Application 10/659,036
Filed on 2003-09-09

METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE

  • Read more about METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE
United Kingdom
95909917.7
Filed on 1994-12-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1106
  • Page 1107
  • Page 1108
  • Page 1109
  • Page 1110
  • Page 1111
  • Page 1112
  • Page 1113
  • Page 1114
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health